Improve your knowledge in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer through this program, where you will find the best didactic material with real clinical cases. Learn here about the latest advances in the specialty to be able to provide quality medical care"

In this way, we analyze the diagnostic and therapeutic management of both primary and metastatic brain tumors. We will discuss current technologies used for the resection of gliomas, such as awake craniotomy, fluorescence-guided surgery, neuronavigation, neuroendoscopy, among many others.

Another advance that will be widely seen comes from the field of genomics whose advances have made it possible to learn that more than half of pediatric brain tumors have genetic abnormalities that could help in diagnosis or treatment, which is reflected in the recent decision of the World Health Organization to classify such tumors by genetic alterations, rather than by tumor type. Thus, precision medicine for pediatric brain tumors is now a reality, and possibly in the near future also for adult brain tumors.

Finally, another topic that we will analyze in this Postgraduate Certificate is immunotherapy, highlighting some relevant ones and gaining ground in other tumors. Immunotherapy has shown promise for the treatment of glioblastoma multiforme. This is because glioblastoma multiforme exhibits powerful adaptive capabilities, a relative lack of immunogenicity, an immunosuppressive tumor microenvironment and intratumoral heterogeneity. Therefore, experts agree that immune-targeted therapies are likely to play a central role in improving the durability of treatment. To date, clinical trials of several vaccine therapies using autologous tumor antigens or specific tumor-associated antigenic peptides with adjuvants have been conducted to treat patients with high-grade gliomas. Therefore, immunotherapy, especially combination therapy, may be a promising strategy for the treatment of patients with brain tumors.

In short, many concepts are currently being investigated that are expected to have a positive influence on the therapeutic treatment of metastatic and primary tumors of the central nervous system, and which TECH will discuss since many have already been integrated into routine clinical practice and others will soon preparation part of the wide range of options in the broad diagnostic or therapeutic arsenal existing today.

Update your knowledge through this postgraduate certificate in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer”

This postgraduate certificate in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer contains the most complete and up-to-date scientific program on the market. The most important features include:

• Development of more than 75 clinical cases presented by experts in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer
• The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• Diagnostic-therapeutic developments on evaluation, diagnosis, and treatment in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer
• It contains practical exercises where the self-assessment process can be carried out to improve learning
• Iconography of clinical and diagnostic imaging tests
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• With special emphasis on evidence-based medicine and research methodologies in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer
• All this will be complemented with theoretical lessons, questions to the expert, discussion forums on controversial topics and individual reflection work
• Availability of the contents from any fixed or portable device with an internet connection

This postgraduate certificate is the best investment you can make when selecting a refresher program for two reasons: in addition to updating your knowledge of Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer, you will also obtain a qualification from TECH”

The teaching staff includes professionals from the field Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer, who bring their experience to this educational program, as well as renowned specialists from leading scientific communities.

Thanks to its multimedia content developed with the latest educational technology, they will allow the professional a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to prepare in real situations.

This program is designed around Problem-Based Learning, where students must try to solve the different professional practice situations that arise during this academic course. For this purpose, the physician will be assisted by an innovative interactive video system created by renowned and experienced experts in the field Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer with extensive teaching experience.

Increase your decision-making confidence by updating your knowledge through this postgraduate certificate"

Take the opportunity to learn about the latest advances in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer and improve your patient care"

This postgraduate certificate in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer is aimed at facilitating physicians’ performance in treating neurological oncological pathologies.

This postgraduate certificate designed to update your knowledge of Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer, with the use of the latest educational technology, to contribute quality and safety to decision making, diagnosis, treatment and patient support”

General Objective

• Create a global and up-to-date vision of the Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer and all its aspects, allowing students to acquire useful knowledge while they generate interest in expanding the information and discovering its application in their daily practice

Specific Objectives

• Study paraneoplastic cerebellar degeneration, paraneoplastic sensory neuronopathy and more paraneoplastic syndromes
• Address new developments in the approach to necrotizing myopathies and paraneoplastic dermatomyositis
• Know the neurological complications of leukemia, digestive tumors, nephrourinary cancer and sarcomas
• Delve into the neuro-oncology of gynecological cancer

Make the most of the opportunity and take the step to get up to date on the latest developments in Management of Paraneoplastic Syndromes and Comorbidities in Neurological Cancer"